探索检测极限:利用游离DNA进行胚胎非整倍体筛查的研究
前瞻性队列研究在学术生育中心纳入9例IVF患者,使用41枚捐赠双原核胚胎和20枚PGT-A胚胎的废弃培养液,比较第3天和第5天游离DNA与全胚胎或滋养层活检的一致性。第5天游离DNA对非整倍体的敏感性0.8、特异性0.61,阳性预测值0.47、阴性预测值0.88;作者认为游离DNA用于PGT-A需进一步优化才能临床实施。
要点
- 第3天和第5天废弃培养液中游离DNA扩增率分别为39%和80.4%。
- 第5天游离DNA与滋养层活检的倍性和性别一致性分别为65%和70%。
- 辅助孵化时机和形态学分级不影响游离DNA浓度或准确性。
核心结论
- 游离DNA在第3天和第5天均可检测到,但第5天更准确;尽管数据显示中等一致性,使用游离DNA的PGT-A在临床实施前必须进一步优化。
研究设计与样本
- 前瞻性队列研究,在学术生育中心纳入9例接受IVF的患者,使用41枚捐赠双原核胚胎和20枚来自接受PGT-A患者的胚胎。
- 捐赠胚胎组在第3天和第5天收集废弃培养液,一半胚胎在收集前进行辅助孵化、一半在收集后进行;临床组在第5天滋养层活检前收集废弃培养液。
- 样本采用下一代测序进行PGT-A,游离DNA结果与对应全胚胎和滋养层活检比较。
主要发现
- 141份样本中,第3天和第5天废弃培养液游离DNA扩增率分别为39%和80.4%。
- 第3天游离DNA与全胚胎的倍性和性别一致性分别为56.3%和81.3%。
- 第5天游离DNA与滋养层活检的倍性和性别一致性分别为65%和70%。
- 第5天游离DNA对非整倍体的敏感性为0.8、特异性为0.61,阳性预测值为0.47、阴性预测值为0.88。
- 辅助孵化时机和形态学分级不影响游离DNA浓度或准确性。
临床怎么用
- 作者认为使用游离DNA的PGT-A在临床实施前必须进一步优化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the accuracy of cell-free DNA (cfDNA) in spent embryo medium (SEM) for ploidy and sex detection at the cleavage and blastocyst stages. To determine if assisted hatching (AH) and morphologic grade influence cfDNA concentration and accuracy. DESIGN: Prospective cohort. SETTING: Academic fertility center. PATIENT(S): Nine patients undergoing IVF; 41 donated two-pronuclei embryos and 20 embryos from patients undergoing preimplantation genetic testing for aneuploidy (PGT-A). INTERVENTIONS(S): In a donated embryo arm, SEM was collected on days 3 and 5, with one-half of the embryos undergoing AH before and one-half after. In a clinical arm, SEM was collected on day 5 before trophectoderm (TE) biopsy. Samples underwent PGT-A with the use of next-generation sequencing. cfDNA results were compared with corresponding whole embryos and TE biopsies. MAIN OUTCOME MEASURE(S): Concordance rates, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for ploidy and sex detection with the use of cfDNA. RESULT(S): Of 141 samples, cfDNA was amplified in 39% and 80.4% of days 3 and 5 SEM, respectively. Concordances for ploidy and sex, respectively, were 56.3% and 81.3% between day 3 cfDNA and whole embryos, and 65% and 70% between day 5 cfDNA and TE biopsies. Day 5 cfDNA sensitivity and specificity for aneuploidy were 0.8 and 0.61, respectively. PPV and NPV were 0.47 and 0.88, respectively. Timing of AH and morphology did not influence cfDNA concentration or accuracy. CONCLUSION(S): cfDNA is detectable on days 3 and 5, but more accurate on day 5. Although our data suggest moderate concordance rates, PGT-A with the use of cfDNA must be further optimized before clinical implementation.
引用
- Ho JR, Arrach N, Rhodes-Long K, et al. Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos. Fertil Steril. 2018. PMID: 29960707. doi:10.1016/j.fertnstert.2018.03.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。